Depression had remitted in six of the 10 women by the end of the trial. Three additional subjects met the criteria for response, and one subject had no response to treatment. Degree of remission was not associated with the demographic or clinical characteristics of the patients. No patients reported any adverse effects. Overall, the subjects’ mood had improved after the first week of treatment (t=2.61, df=9, p<0.05). This improvement continued throughout the study (F=10.71, df=8, 112, p<0.001).